# Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma

> **NCT03900871** · EARLY_PHASE1 · UNKNOWN · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT03900871
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-10
- **Primary completion:** 2020-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03900871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03900871, "Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03900871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*